Colon Biopsy Classification Using Crypt Architecture

Author(s):  
Assaf Cohen ◽  
Ehud Rivlin ◽  
Ilan Shimshoni ◽  
Edmond Sabo
Keyword(s):  
1962 ◽  
Vol 42 (2) ◽  
pp. 157-159 ◽  
Author(s):  
Eugene J. Gangarosa ◽  
William R. Beisel

2013 ◽  
pp. 688-708
Author(s):  
Stanislaw Osowski ◽  
Michal Kruk ◽  
Robert Koktysz ◽  
Jaroslaw Kurek

This chapter presents the computerized system for automatic analysis of the medical image of the colon biopsy, able to extract the important diagnostic knowledge useful for supporting the medical diagnosis of the inflammatory bowel diseases. Application of the artificial intelligence methods included in the developed automatic system allowed the authors to obtain the unique numerical results, impossible for achieving at the visual inspection of the image by the human expert. The developed system enabled the authors to perform all steps in an automatic way, including the segmentation of the image, leading to the extraction of all glandular ducts, parameterization of the individual ducts and creation of the diagnostic features, as well as characterizing the recognition problem. These features put to the input of SVM classifier enable to associate them with the stage of development of the inflammation. The numerical experiments have shown that the system is able to process successfully the images at different stages of development of the inflammation. Its important advantage is automation of this very difficult work, not possible to be done manually, even by a human expert.


Pathogens ◽  
2020 ◽  
Vol 9 (12) ◽  
pp. 1003
Author(s):  
Jacky Flipse ◽  
Birgitta Duim ◽  
Janny A. Wallinga ◽  
Laetitia R. H. de Wijkerslooth ◽  
Linda van der Graaf-van Bloois ◽  
...  

A man with a well-controlled HIV infection, previously diagnosed with lymphogranuloma venereum and treated for Hodgkin’s lymphoma, was suffering from chronic diarrhea. He travelled to Indonesia in the month prior to the start of complaints. Over a 15-month period, sequences related to Campylobactertroglodytis/upsaliensis, C. pinnepediorum/mucosalis/concisus and C. hominis were detected by 16S rRNA qPCR-based assays in various stool samples and in a colon biopsy. Culture revealed the first isolation of “candidatus Campylobacter infans”, a species identified recently by molecular methods only. The patient was treated with azithromycin, ciprofloxacin and tetracycline. To identify potential continuous exposure of the patient to Campylobacter, stool samples of the partner and the cat of the patient were analyzed and C. pinnepediorum/mucosalis/concisus and C. helveticus, respectively, were detected. The diversity in detected species in this immunocompromised patient with a lack of repeatedly consistent findings resulted in the conclusion that not any of the Campylobacter species was the primary cause of the clinical condition. This study shows the challenges in detection and interpretation of diagnostic results regarding Campylobacter.


2014 ◽  
Vol 47 ◽  
pp. 76-92 ◽  
Author(s):  
Saima Rathore ◽  
Mutawarra Hussain ◽  
Muhammad Aksam Iftikhar ◽  
Abdul Jalil

2006 ◽  
Vol 63 (5) ◽  
pp. AB108 ◽  
Author(s):  
Stephan R. Vavricka ◽  
Alexander Imhof ◽  
Stephan Wildi ◽  
Radu Tutuian ◽  
Peter Bauerfeind ◽  
...  

2013 ◽  
Vol 4 (1) ◽  
pp. 95-99 ◽  
Author(s):  
Darya Olegovna Markova ◽  
Ruslan Abdullayevich Nasyrov ◽  
Mariya Olegovna Revnova

Cytomegalovirus infection of the gastrointestinal tract is a relatively common occurrence in patients receiving immunosuppressive drugs, those infected with HIV, or those who are transplantant recepients. CMV infection may be diagnosed if typical intranuclear inclusion bodies are seen on standard hematoxylin and eosin (H&E) stain. However, the sensitivity of H&E exam for CMV infection is low. Immunohistochemistry (IHC) exam performed on colon biopsy specimens is more sensitive than routine histologic exam and has excellent specificity. Currently IHC is considered the gold standard for detecting CMV CMV infection in patients with refractory or complicated IBD should be ruled out before aggressive immunosuppressive therapy for treatment-resistant disease to decrease morbidity and mortality.


Sign in / Sign up

Export Citation Format

Share Document